Delivery Order SPE2DB20D3104-SPE2DB23FV6M1

Award Date 5/1/23
Potential Completion Date 5/2/23
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, worth $1,743.42, is for the delivery of Prolia 60 mg/mL syringes. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer for Amerisourcebergen's federal contracting activities. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $20,921.04 firm fixed price delivery order is for the supply of Prolia 60 mg/ml syringes. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $50,990.06 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,260.68 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The award has an ultimate completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $16,976.52 with a period of performance through April 30, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Prolia 60 mg/ml syringes, a specialty medication used for the treatment of various medical conditions. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $37,757.81 award is for the supply of PROLIA 60 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract worth $3,486.84 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Prolia 60 mg/mL syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award, valued at $31,381.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Prolia 60 mg/ml syringes, a pharmaceutical product, with a period of performance through July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,428.70, is a delivery order for the drug Prolia 60 mg/ml syringe. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price arrangement. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,358.55 firm fixed price delivery order is for the provision of PROLIA 60 MG/ML syringes. The contract does not have a set-aside designation. This award is associated with Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV6M1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.44 delivery order is for the supply of the drug Prolia 60 mg/ml syringes. The contract has a firm fixed price and is set to be completed by May 2, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate IDC valued at up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 9:50 AM